Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×
Oxigene, Inc.
Biological Products Except Diagnostic Substances CA, United States
Nasdaq: OXGN
Company Description
Oxigene, Inc. is a clinical-stage biopharmaceutical company, which develops novel small molecule therapeutics to treat cancer and eye diseases. Its primary focus is in the development of product candidates referred to as vascular disrupting agents, which selectively disable and destroy abnormal blood vessels that provide solid tumors and also are associated with visual impairment in a number of ophthalmological diseases and conditions. Oxigene was founded in 1988 and is headquartered in South San Francisco, CA.
Similar to: Retrophin Inc, BioTime, Inc., Cardium Therapeutics, Inc.
Featured Company
Fidelity Asian Values Plc
Tadworth, SU, GB
Fidelity Asian Values Plc is a Closed-End Investment Fund/Investment. The company invests in information technology, energy, financial… Learn more →
Social Monitor
You may also be interested in:
Cardium Therapeutics, Inc.
San Diego, CA, US
Cardium Therapeutics, Inc. is an asset-based, health sciences and regenerative medicine company focused on acquiring and strategically… Learn more →
BioTime, Inc.
Alameda, CA, US
BioTime, Inc. is a biotechnology company focused on regenerative medicine and blood plasma volume expanders. Its broad platform of… Learn more →
Retrophin Inc
New York, NY, US
Retrophin, Inc. (OTCQB: RTRX) New York-based, biotechnology company focused on discovering and developing treatments for rare and… Learn more →